Layla Van Doren

Layla Van Doren, MD, MBA, is an Assistant Professor of Medicine (Hematology) at Yale School of Medicine and serves as Director of the MS1 Hematology Course and Director of Education for the Adult Sickle Cell Program. She is affiliated with Smilow Cancer Hospital and the Yale Cancer Center.

Education:

• MD: George Washington University School of Medicine and Health Sciences
• MBA: Loma Linda University, Healthcare Administration
• BA: California State University, San Bernardino (Art History; minor in Biology)
• Residency: University of Southern California (Internal Medicine)
• Fellowship: Tufts Medical Center (Hematology & Oncology)

Research & Clinical Focus:

• Mechanisms of blood platelet disorders and development of novel therapies
• Clinical specialization in sickle cell disease, bleeding/clotting disorders, and women’s health-related hematology
• Pathophysiology of GPR31 in platelet activation (research during fellowship)

Affiliations:

• Hereditary Hemorrhagic Telangiectasia (HHT) Program
• Sickle Cell Program at Smilow Cancer Hospital
• Classical Hematology division

Key Contributions: Advocacy for patient and provider education to improve outcomes in hematology. Active participant in national hematology conferences (e.g., American Society of Hematology).